SENS-501

N/A

Report date: 2024/03/07 11:52:36

Base Information

Drug NameSENS-501

Drug Alias NameAdeno‐associated viral vector serotype 8 containing the 3' human otoferlin coding sequence, adeno‐associated viral vector serotype 8 containing the 5' human otoferlin coding sequenceAAV-8 containing the 3' human otoferlin coding sequence, AAV-8 containing the 5' human otoferlin coding sequenceSENS-501SENS501OTOF-GT

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionOtoferlin gene transference

TargetsOtoferlin

Therapy Area/IndicationsHearing Loss, SensorineuralDeafnessHearing Loss +[6]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesEuropeAustralia +[4]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesInstitut Pasteur

China Registration ClassN/A

Develop Information

Active CompaniesSensorion Sa

Inactive CompaniesN/A

Active IndicationsHearing Loss, SensorineuralDeafnessHearing Loss +[5]

Inactive IndicationsOtorhinolaryngologic Diseases

Other Information

ATC CodeN/A